Envista Holdings Corporation (NYSE: NVST) ("Envista") -- Envista and leading dental support organization Pacific Dental Services® (PDS) announce today the consummation of a multi-year year...

Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that it closed the previously disclosed divestiture of its KaVo Treatment Unit & Instrument business. Envista received $317.3...

Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the U.S. Food and Drug Administration (FDA) has cleared the Nobel Biocare N1™ implant system. Boasting a biologically...

Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced an update to the company's participation at the 40th Annual J.P. Morgan Healthcare Conference. Envista will present virtually...

Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced it has entered into a definitive agreement to acquire Carestream Dental's Intra-Oral Scanner (IOS) business for $600 million....

Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in the following upcoming investor conferences: Stifel MedTech Madness 2021 Annual West...

Envista Holdings Corporation (NYSE: NVST) today announced results for the third quarter 2021. As previously disclosed, in September we reached an agreement to sell our KaVo Treatment Unit and...

Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its third quarter 2021 on Wednesday, November 3, 2021. Envista will discuss these results on a conference...

Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced it entered into a binding agreement to sell its KaVo Treatment Unit and Instrument business to planmeca Verwaltungs GmbH...

Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in the Baird Global Healthcare Virtual Conference on Tuesday, September 14, 2021 at 2:35 PM...